| Literature DB >> 31581507 |
Mikel Añibarro-Ortega1, José Pinela2, Lillian Barros3, Ana Ćirić4, Soraia P Silva5, Elisabete Coelho6, Andrei Mocan7,8, Ricardo C Calhelha9, Marina Soković10, Manuel A Coimbra11, Isabel C F R Ferreira12.
Abstract
This work aimed to characterize compositional and bioactive features of Aloe vera leaf (fillet, mucilage, and rind) and flower. The edible fillet was analysed for its nutritional value, and all samples were studied for phenolic composition and antioxidant, anti-inflammatory, antimicrobial, tyrosinase inhibition, and cytotoxic activities. Dietary fibre (mainly mannan) and available carbohydrates (mainly free glucose and fructose) were abundant macronutrients in fillet, which also contained high amounts of malic acid (5.75 g/100 g dw) and α-tocopherol (4.8 mg/100 g dw). The leaf samples presented similar phenolic profiles, with predominance of chromones and anthrones, and the highest contents were found in mucilage (131 mg/g) and rind (105 mg/g) extracts, which also revealed interesting antioxidant properties. On the other hand, the flower extract was rich in apigenin glycoside derivatives (4.48 mg/g), effective against Pseudomonas aeruginosa (MIC = 0.025 mg/mL and MBC = 0.05 mg/mL) and capable of inhibiting the tyrosinase activity (IC50 = 4.85 mg/mL). The fillet, rind, and flower extracts also showed a powerful antifungal activity against Aspergillus flavus, A. niger, Penicillium funiculosum, and Candida albicans, higher than that of ketoconazole. Thus, the studied Aloe vera samples displayed high potential to be exploited by the food or cosmetic industries, among others.Entities:
Keywords: Aloe barbadensis Mill.; antimicrobial activity; antioxidant capacity; cytotoxicity; neutral sugars; nutritional composition; organic acids; phenolic compounds; tyrosinase inhibitory activity
Year: 2019 PMID: 31581507 PMCID: PMC6826699 DOI: 10.3390/antiox8100444
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Nutritional value and organic acids and tocopherols composition of Aloe vera fillet.
| Nutritional Component | Fresh Fillet | Dry Powder |
|---|---|---|
| Moisture (g/100 g) 1 | 98 ± 1 | - |
| Protein (g/100 g) | 0.044 ± 0.001 | 2.60 ± 0.05 |
| Ash (g/100 g) | 0.150 ± 0.003 | 9.0 ± 0.2 |
| Fat (g/100 g) | 0.0168 ± 0.0006 | 1.00 ± 0.04 |
| Available carbohydrates (g/100 g) | 0.630 ± 0.006 | 37.4 ± 0.3 |
| Dietary fibre (g/100 g) | 0.84 ± 0.02 | 50.1 ± 0.3 |
| Crude fibre (g/100 g) | 0.120 ± 0.003 | 7.1 ± 0.2 |
| Energy (kcal/100 g) | 4.54 ± 0.05 | 269 ± 3 |
| Oxalic acid (mg/100 g) | 2.39 ± 0.04 | 142 ± 2 |
| Quinic acid (mg/100 g) | 11.63 ± 0.07 | 689 ± 4 |
| Malic acid (mg/100 g) | 97 ± 1 | 5750 ± 66 |
| Total organic acids (mg/100 g) | 111 ± 1 | 6581 ± 73 |
| α-Tocopherol (µg/100 g) | 81 ± 2 | 4813 ± 104 |
| β-Tocopherol (µg/100 g) | 3.59 ± 0.06 | 213 ± 3 |
| γ-Tocopherol (µg/100 g) | 6.7 ± 0.1 | 396 ± 8 |
| δ-Tocopherol (µg/100 g) | 1.78 ± 0.02 | 106 ± 1 |
| Total tocopherols (µg/100 g) | 93 ± 2 | 5527 ± 98 |
1 The results are presented as mean ± standard deviation.
Fatty acids composition of Aloe vera fillet.
| Fatty Acid | Relative Percentage (%) 1 |
|---|---|
| Caproic acid (C6:0) | 0.51 ± 0.01 |
| Caprylic acid (C8:0) | 0.21 ± 0.01 |
| Capric acid (C10:0) | 0.70 ± 0.01 |
| Lauric acid (C12:0) | 6.83 ± 0.09 |
| Myristic acid (C14:0) | 3.57 ± 0.06 |
| Pentadecanoic acid (C15:0) | 0.41 ± 0.02 |
| Palmitic acid (C16:0) | 32.1 ± 0.6 |
| Heptadecanoic acid (C17:0) | 0.92 ± 0.02 |
| Stearic acid (C18:0) | 16.4 ± 0.2 |
| Oleic acid (C18:1n9c) | 12.9 ± 0.1 |
| Linoleic acid (C18:2n6c) | 15.0 ± 0.2 |
| α-Linolenic acid (C18:3n3) | 4.00 ± 0.07 |
| Arachidic acid (C20:0) | 0.689 ± 0.008 |
| Heneicosanoic acid (C21:0) | 0.212 ± 0.002 |
| Behenic acid (C22:0) | 1.14 ± 0.01 |
| Erucic acid (C22:1) | 0.95 ± 0.01 |
| Tricosanoic acid (C23:0) | 0.86 ± 0.04 |
| Lignoceric acid (C24:0) | 2.54 ± 0.01 |
| Saturated fatty acids (SFA) | 67 ± 1 |
| Monounsaturated fatty acids (MUFA) | 13.8 ± 0.04 |
| Polyunsaturated fatty acids (PUFA) | 19.0 ± 0.2 |
1 The results are presented as mean ± standard deviation.
Carbohydrates of the initial and dialysed Aloe vera fillet identified as alditol acetates.
| Fillet Sample | Carbohydrate (mol%) | Total Carbohydrate | ||||||
|---|---|---|---|---|---|---|---|---|
| Ara | Xyl | Man | Gal | Glc | UA | (g/100 g) | RSD (%) | |
|
| ||||||||
| | 1.0 | 2.0 | 21.4 | 3.5 | 50.1 | 22.0 | 64.0 | 3 |
| | 9.7 | 90.3 | 34.9 | 12 | ||||
|
| 1.4 | 1.5 | 65.2 | 3.2 | 15.9 | 12.7 | 76.5 | 6 |
HMW: high molecular weight (sample dialysed with a membrane cut-off of 12–14 kDa). Ara: arabinose; Xyl: xylose; Man: mannose; Gal: galactose; Glc: glucose; UA: uronic acids; RSD: relative standard deviation.
Glycosidic-linkage composition of the dialysed Aloe vera fillet.
| Glycosyl Linkage | HMW (> 14 kDa) | |
|---|---|---|
| % mol | RSD (%) | |
| 0.4 | 7 | |
| 0.5 | 24 | |
| 5-Ara | 0.7 | 2 |
|
|
|
|
| 0.2 | 9 | |
| 4-Xylp | 1.7 | 21 |
|
|
|
|
| 1.0 | 16 | |
| 4-Man | 74.0 | 0 |
| 2,4-Man | 1.6 | 36 |
| 3,4-Man | 1.1 | 35 |
| 4,6-Man | 2.6 | 12 |
|
|
|
|
| 0.5 | 28 | |
|
|
|
|
| 0.6 | 3 | |
| 4-Glc | 14.0 | 7 |
| 4,6-Glc | 1.1 | 17 |
|
|
|
|
|
| 77.4 | |
|
| 3.2 | |
HMW: high molecular weight (sample dialysed with a membrane cut-off of 12–14 kDa). RSD: relative standard deviation.
Phenolic compounds identified in Aloe vera leaf and flower extracts. Retention time (Rt), wavelengths of maximum absorption in the UV-vis region (λmax), pseudomolecular and MS2 fragment ions, and relative abundance in brackets.
| Peak | Rt (min) | λmax (nm) | [M−H]− ( | MS2 ( | Tentative Identification 1 | Reference |
|---|---|---|---|---|---|---|
| 1 | 6.14 | 227, 245, 252, 298 | 393 | 375(3), 303(12), 273(100), 245(5), 203(3) | Aloesin (aloeresin B) isomer 1 | [ |
| 2 | 7.13 | 213, 243, 252, 299 | 393 | 375(3), 303(14), 273(100), 245(4), 203(3) | Aloesin (aloeresin B) isomer 2 | [ |
| 3 | 7.73 | 213, 244, 252, 299 | 455 | 473(5), 411(5), 391(7), 365(100), 341(3), 333(11), 275(3), 243(3) | Unknown | - |
| 4 | 9.56 | 254, 271, 345 | 609 | 447(100), 357(5), 327(15) | Luteolin-6,8- | [ |
| 5 | 11.53 | 306 | 337 | 191(100), 173(5), 163(10), 119(3) | [ | |
| 6 | 12.63 | 306 | 337 | 191(100), 173(5), 163(10), 119(3) | [ | |
| 7 | 13.41 | 270, 340 | 593 | 473(43), 431(100), 311(79) | Apigenin-6,8- | [ |
| 8 | 14.71 | 254, 271, 346 | 447 | 357(52), 327(100) | Luteolin-6- | [ |
| 9 | 15.98 | 222, 272, 303, 355 | 433 | 343(3), 313(100), 271(5), 255(3) | 10-Hydroxyaloin B | [ |
| 10 | 16.36 | 222, 273, 305, 355 | 433 | 343(3), 313(100), 271(5), 255(3) | 10-Hydroxyaloin A | [ |
| 11 | 17.60 | 227, 272, 301, 350 | 433 | 343(5), 313(37), 271(100), 255(3) | 5-Hydroxyaloin A | [ |
| 12 | 18.11 | 272, 340 | 431 | 413(8), 341(27), 311(100) | Apigenin-6- | [ |
| 13 | 18.88 | 219, 269, 301, 357 | 505 | 448(3), 343(100), 172(5) | 6′-Malonylnataloin | [ |
| 14 | 23.97 | 225, 269, 298, 355 | 417 | 297(100), 255(3) | Aloin B (isobarbaloin) | [ |
| 15 | 25.71 | 225, 269, 298, 355 | 417 | 297(100), 255(3) | Aloin A (barbaloin) | [ |
| 16 | 26.56 | 225, 269, 298, 355 | 503 | 459(100), 417(5), 297(40) | Malonyl aloin B | - |
| 17 | 27.62 | 229, 252, 300 | 553 | 407(100), 375(5), 347(11), 275(52), 259(5), 233(7), 191(4) | 2’- | [ |
| 18 | 28.01 | 225, 269, 298, 355 | 503 | 459(100), 417(5), 297(48) | Malonyl aloin A | - |
| 19 | 36.41 | 252, 284 | 585 | 567(5), 521(18), 495(100), 463(3), 373(3), 333(3) | Unknown | - |
| 20 | 7.13 | 298, 324 | 353 | 191(100), 179(10), 173(5), 135(3) | 5- | [ |
| 21 | 9.53 | 254, 271, 345 | 609 | 447(100), 357(5), 327(15) | Luteolin-6,8- | [ |
| 22 | 13.34 | 270, 340 | 593 | 473(43), 431(100), 311(79) | Apigenin-6,8- | [ |
| 23 | 14.71 | 254, 271, 346 | 447 | 357(52), 327(100) | Luteolin-6- | [ |
| 24 | 15.80 | 270, 340 | 593 | 473(43), 431(100), 311(79) | Apigenin-6,8- | [ |
| 25 | 16.50 | 271, 340 | 563 | 443(7), 413(100), 323(5), 311(3), 293(27) | Apigenin-2’’- | [ |
| 26 | 17.70 | - | 593 | 473(8), 443(100), 371(3), 353(3), 341(3), 323(28), 311(9), 285(3) | Methyl-luteolin-2’’- | [ |
| 27 | 18.14 | 272, 340 | 431 | 413(8), 341(27), 311(100) | Apigenin-6- | [ |
1 The compounds identity was attributed by interpreting data acquired from HPLC-DAD-ESI/MSn with those of the literature.
Figure 1HPLC phenolic profiles of Aloe vera rind and mucilage extracts recorded at 280 nm (A1 and B1, respectively) and 370 nm (A2 and B2, respectively). See Table 5 for peak identification.
Figure 2HPLC phenolic profile of Aloe vera flower extract recorded at 370 nm. See Table 5 for peak identification.
Content of phenolic compounds in Aloe vera leaf (fillet, mucilage, and rind) and flower extracts. See Table 5 for peak identification.
| Peak | Content (mg/g Extract) 1 | Statistics | ||||
|---|---|---|---|---|---|---|
| Fillet | Mucilage | Rind | Flower | H 2 | ||
| 1 | 5.4 ± 0.4 c | 39 ± 3 a | 34.4 ± 0.7 b | - | 0.176 | <0.001 |
| 2 | - | - | 4.8 ± 0.2 | - | - | - |
| 4 | - | 3.5 ± 0.2 | tr | - | - | - |
| 5 | 0.180 ± 0.008 | - | 0.31 ± 0.01 | - | 0.560 | <0.001* |
| 6 | 0.145 ± 0.002 | - | - | - | - | - |
| 7 | - | - | 6.67 ± 0.04 | - | - | - |
| 8 | tr | 0.79 ± 0.01 b | 3.3 ± 0.1 a | - | 0.095 | <0.001 |
| 9 | tr | 3.2 ± 0.2 a | 2.83 ± 0.06 b | - | 0.120 | <0.001 |
| 10 | tr | 5.1 ± 0.4 a | 3.8 ± 0.2 b | - | 0.149 | <0.001 |
| 11 | - | 3.35 ± 0.06 | 2.4 ± 0.2 | - | 0.286 | <0.001* |
| 12 | - | - | 1.64 ± 0.05 | - | - | - |
| 13 | - | - | 3.23 ± 0.04 | - | - | - |
| 14 | 0.24 ± 0.03 c | 13.3 ± 0.1 a | 4.3 ± 0.3 b | - | 0.240 | <0.001 |
| 15 | 1.24 ± 0.06 c | 22.2 ± 0.5 a | 9.9 ± 0.4 b | - | 0.292 | <0.001 |
| 16 | 1.43 ± 0.08 c | 16.6 ± 0.4 a | 7.8 ± 0.4 b | - | 0.350 | <0.001 |
| 17 | 0.13 ± 0.04 c | 6.08 ± 0.08 b | 6.9 ± 0.4 a | - | 0.139 | <0.001 |
| 18 | 2.4 ± 0.1 c | 17.6 ± 0.2 a | 12.8 ± 0.8 b | - | 0.157 | <0.001 |
| 20 | - | - | - | 0.30 ± 0.01 | - | - |
| 21 | - | - | - | tr | - | - |
| 22 | - | - | - | 2.42 ± 0.04 | - | - |
| 23 | - | - | - | tr | - | - |
| 24 | - | - | - | 0.94 ± 0.01 | - | - |
| 25 | - | - | - | 0.96 ± 0.01 | - | - |
| 26 | - | - | - | tr | - | - |
| 27 | - | - | - | 0.152 ± 0.009 | - | - |
|
| 0.33 ± 0.01 a | - | 0.31 ± 0.01 a,b | 0.30 ± 0.01 b | 0.735 | 0.022 |
|
| - | 4.3 ± 0.2 b | 11.6 ± 0.1 a | 4.48 ± 0.05 b | 0.298 | <0.001 |
|
| 5.3 ± 0.3 c | 81 ± 1 a | 47 ± 2 b | - | 0.291 | <0.001 |
|
| 5.5 ± 0.5 b | 45 ± 3 a | 46 ± 1 a | - | 0.259 | <0.001 |
|
| 11.2 ± 0.2 c | 131 ± 3 a | 105 ± 3 b | 4.78 ± 0.05 d | 0.134 | <0.001 |
tr: traces. 1 The results are presented as mean ± standard deviation. 2 Homoscedasticity (H) was tested by the Levene’s test: p > 0.05 indicates homoscedasticity and p < 0.05 indicates heteroscedasticity. 3 Statistically significant differences (p < 0.05) among two samples* were assessed by a Student’s t-test and among more than two samples were assessed by a one-way ANOVA (and indicated by different letters), using Tukey’s honestly significant difference (HSD) or Tamhane’s T2 multiple comparison tests, when homoscedasticity was verified or not, respectively.
Antioxidant, anti-tyrosinase, and antimicrobial capacities of Aloe vera leaf (fillet, mucilage, and rind) and flower extracts and positive controls.
| Fillet | Mucilage | Rind | Flower | Positive Control | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Trolox | |||||||||
| OxHLIA (IC50, µg/mL) | 378 ± 18 a | 105 ± 8 b | 56 ± 4 c | 80 ± 4 b,c | 20.4 ± 0.4 d | |||||
| TBARS (EC50, µg/mL) | 87 ± 4 b | 47 ± 2 c | 97 ± 3 b | 347 ± 14 a | 5.4 ± 0.3 d | |||||
| β-CBI (EC50, µg/mL) | 78 ± 6 a | 63 ± 4 b | 51 ± 4 c | 59 ± 4 b,c | 0.20 ± 0.01 d | |||||
|
| Kojic Acid | |||||||||
| IC50 (mg/mL) or I(%) 2 | na | 30.38 ± 0.01% | 27.2 ± 0.7% | 4.85 ± 0.07 | 0.078 ± 0.001 | |||||
|
| Streptomycin | |||||||||
| MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | |
|
| 0.60 | 0.80 | 0.60 | 0.80 | 0.60 | 0.80 | 0.60 | 0.80 | 0.006 | 0.012 |
|
| 0.60 | 0.80 | 0.40 | 0.80 | 0.40 | 0.80 | 0.60 | 0.80 | 0.003 | 0.006 |
|
| 0.40 | 0.80 | 0.20 | 0.40 | 0.40 | 0.80 | 0.40 | 0.80 | 0.025 | 0.050 |
|
| 0.80 | 1.60 | 0.60 | 0.80 | 0.80 | 1.20 | 0.40 | 0.80 | 0.20 | 0.30 |
|
| 1.20 | 1.60 | 0.40 | 0.80 | 0.60 | 0.80 | 0.80 | 1.20 | 0.20 | 0.30 |
|
| 0.050 | 0.10 | 0.10 | 0.20 | 0.025 | 0.050 | 0.025 | 0.050 | 0.006 | 0.012 |
|
| 0.10 | 0.20 | 0.050 | 0.10 | 0.10 | 0.20 | 0.025 | 0.050 | 0.025 | 0.050 |
| 0.80 | 1.20 | 0.80 | 1.20 | 0.40 | 0.80 | 0.80 | 1.20 | 0.25 | 0.50 | |
|
| Ketoconazole | |||||||||
| MIC | MFC | MIC | MFC | MIC | MFC | MIC | MFC | MIC | MFC | |
|
| 0.10 | 0.20 | 0.80 | >1.60 | 0.10 | 0.20 | 0.10 | 0.20 | 0.25 | 0.50 |
|
| 0.10 | 0.20 | >1.60 | >1.60 | 0.20 | 0.40 | 0.10 | 0.20 | 0.20 | 0.50 |
|
| 0.050 | 0.10 | >1.60 | >1.60 | 0.050 | 0.10 | 0.10 | 0.20 | 0.20 | 0.50 |
|
| 0.050 | 0.10 | 0.050 | 0.10 | 0.050 | 0.10 | 0.050 | 0.10 | 0.40 | 0.80 |
|
| 0.10 | 0.20 | 0.10 | 0.20 | 0.20 | 0.40 | 0.10 | 0.20 | 0.012 | 0.025 |
|
| 0.025 | 0.050 | 0.025 | 0.050 | 0.012 | 0.025 | 0.050 | 0.10 | 0.0015 | 0.003 |
|
| 0.025 | 0.050 | 0.20 | 0.40 | 0.050 | 0.10 | 0.012 | 0.025 | 0.006 | 0.012 |
|
| 0.025 | 0.050 | 0.050 | 0.10 | 0.050 | 0.10 | 0.025 | 0.050 | 0.003 | 0.006 |
na: no activity; MIC: minimum inhibitory concentration (mg/mL); MBC: minimum bactericidal concentration (mg/mL); MFC: minimum fungicidal concentration (mg/mL). 1 Statistics for antioxidant activity: (a) homoscedasticity was tested by the Levene’s test: p = 0.130 for OxHLIA (homoscedastic); p = 0.010 for TBARS (heteroscedastic); and p = 0.305 for β-CBI (homoscedastic); and (b) Statistically significant differences (p < 0.05) were assessed by a one-way ANOVA (and indicated by different letters) using Tukey’s honestly significant difference (HSD) or Tamhane’s T2 multiple comparison tests, when homoscedasticity was verified or not, respectively: p < 0.001 in all cases. 2 Inhibition percentage of tyrosinase activity at 8 mg/mL.